Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA

23. Jun 2021 | 1 min read

Oslo Børs has resolved to admit the shares in Gentian Diagnostics ASA to listing
on Oslo Børs.

It is stipulated that the company prior to the first day of admission to trading
must satisfy the listing requirements on Oslo Børs.

The President and CEO of Oslo Børs determines the first day of listing, no later
than 22 August 2021.

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..